Skip to main content

Walleye Capital LLC

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1758720 NEW YORK, NY

Position in PRTA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,694,072
+$1,203,938 QoQ
Shares Held
277,168
+77.6% QoQ
Ownership
0.540%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRTA Over Time

Shares Held

Position Value (USD)

Derivatives in PRTA

reported options exposure · as of Mar 31, 2026
CallValue
$1,944
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PRTA

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,944 200
2026-03-31 $2,694,072 277,168
2025-12-31 $1,490,134 156,035
2025-12-31 $337,115 35,300
2025-12-31 $7,640 800
2025-09-30 $614 63
2025-09-30 $26,352 2,700
2025-09-30 $461,648 47,300
2025-06-30 $193,633 31,900
2025-06-30 $12,492 2,058
2024-12-31 $207,099 14,953
2024-12-31 $1,385 100
2024-06-30 $16,512 800
2024-06-30 $171,312 8,300
2024-06-30 $951,462 46,098
2024-03-31 $30,194 1,219
2024-03-31 $165,959 6,700
2024-03-31 $108,988 4,400
2023-09-30 $206,799 4,286
2023-09-30 $33,775 700
2023-06-30 $20,484 300
2023-06-30 $3,799,918 55,652
2023-06-30 $198,012 2,900